/ Print /

  • linkedin
  • Increase Font
  • Sharebar

    Fourteen things Trump needs to know about opioids





    3.     Broader access to state prescription drug monitoring programs (PDMPs) will allow insurers to monitor for fraud, waste and abuse of controlled substances


    “This is also critical to allow clinically important coordination of care and discussions about potentially concerning combinations of controlled substances,” Kimberly Lenz, PharmD, clinical pharmacy manager in the UMass Medical School's Office of Clinical Affairs. “Very few states have granted insurers access to the PDMP. Washington State gave their Medicaid program access and noted several benefits, including, better treatment outcomes, better coordination of care, and reduction in costs by a reduction in medically unnecessary prescription drug use and diversion.” 





    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Follow Us On Twitter

    Find us on Facebook

    Latest Tweets Follow